Clinical characteristics and outcomes of ocular allergy in Thai childre
Not Applicable
Completed
- Conditions
- conjunctivitisallergen sensitizationoutcome of treatmentconjunctivitis,allergic conjunctivitis,keratoconjunctivitis,treatment outcome,tacrolimus
- Registration Number
- TCTR20190528001
- Lead Sponsor
- o
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 164
Inclusion Criteria
Children age 4-15 years
History of allergic conjunctivitis
Previously visited at the allergy clinic, Siriraj Hospital
Exclusion Criteria
No
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical characteristics of ocular allergy At the enrollment date chart review
- Secondary Outcome Measures
Name Time Method outcome of treatment At the enrollment date chart review
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ocular allergy in Thai children as studied in TCTR20190528001?
How does tacrolimus compare to standard-of-care treatments for allergic conjunctivitis in pediatric populations?
Are there specific biomarkers for allergen sensitization and treatment outcomes in pediatric ocular allergy?
What adverse events are associated with tacrolimus in treating keratoconjunctivitis in children?
What are the therapeutic implications of TCTR20190528001 findings on ocular allergy management in Southeast Asia?